Proton pump inhibitors and hyporesponsiveness to erythropoiesis stimulating agents in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study
Conclusions This study showed the associations between PPI and ERI, ESA dose, and TSAT in hemodialysis patients; physicians should consider anemia's associations with PPIs in hemodialysis patients.PMID:37935135 | DOI:10.1159/000534701
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Akio Nakashima Yoshia Miyawaki Hirotaka Komaba Noriaki Kurita Yoshihiro Onishi Takashi Yokoo Masafumi Fukagawa Source Type: research
More News: Anemia | Dialysis | Hemodialysis | Iron | Japan Health | Proton Pump Inhibitors PPIs | Study | Urology & Nephrology